longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Hims & Hers Health

HIMS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Forecast & Rating17 analysts currently cover Hims & Hers Health, with about 17.6% giving a positive rating — meaning they expect the stock to rise. The average price target is $31.29, about 12.3% upside from the current price of $27.85. Price targets range from $23.00 to $42.00 — a wide spread, showing clear disagreement over just how much Hims & Hers Health can rise. Historically, about 87.8% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Hims & Hers Health's outlook. Data as of Sep 11, 2026; for reference only and not investment advice.

Sep 11, 2026
Price forecast
$31.2912.34%
Forecast & RatingHold
16analysts
  • Strong buy6.25%
  • Buy12.50%
  • Hold81.25%
  • Sell0.00%
  • Strong sell0.00%
Strong buy
1
Buy
2
Hold
13
Sell
0
Strong sell
0

Target price forecast

Forecast dateSep 14, 2026
Forecast met83.8%
Stock price$27.85
Avg. target$31.3
High target$42
Low target$23
Avg. target
$31.3
High target
$42
Low target
$23
18-month Forecast10/04/202109/14/2026

Analyst ratings

Strong buy
Buy
Hold
Sell
Strong sell

Source: S&P Global

This information is for reference only and is not investment advice.